Source: Eur Respir J 2007; 29: 51-55
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Kinnula V. L., Ilumets H., Myllarniemi M., Sovijarvi A., Rytila P.. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD. Eur Respir J 2007; 29: 51-55

Member's Comments

No comment yet.

Related content which might interest you: 8-isoprostane as a marker of oxidant stress in non-symptomatic cigarette smokers and COPD Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation Year: 2006 Aerobic exercise attenuates pulmonary injury induced by exposure to cigarette smoke Source: Eur Respir J 2012; 39: 254-264 Year: 2012 Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis Source: Eur Respir J 2007; 30: 467-471 Year: 2007 Identification of oxidative stress markers and their association with inflammation in smokers and early chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers Source: Eur Respir J 2005; 26: 835-845 Year: 2005 Tobacco smoke and respiratory disease Source: ISSN=1025-448x, ISBN=1-904097-24-3, page=161 Year: 2002 Passive and active smoking in childhood for COPD Source: Annual Congress 2005 - Does COPD begin in childhood? Reviewing the evidence Year: 2005 Effects of N-acetylcystein on oxidant-antioxidant activity in smokers with chronic obstructive pulmonary disease Source: Annual Congress 2005 - What's new in tobacco and lung disease Year: 2005 Overview of smoking-related disease Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 COPD in Chinese nonsmokers Source: Eur Respir J 2009; 33: 509-518 Year: 2009 Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers Source: Eur Respir J 2013; 41: 1058-1067 Year: 2013 Beyond personal smoking: does environmental tobacco smoke cause chronic obstructive pulmonary disease? Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease Year: 2005 CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005 Tobacco use in relation to COPD and asthma Source: Eur Respir J 2007; 29: 438-445 Year: 2007 Detection of spirometrically-defined COPD in a population of smokers referred to a smoking cessation clinic Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation Year: 2006 Environmental tobacco smoke exposure and the risk of obstructive lung disease exacerbation Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease Year: 2005 Characterisation of a sub-acute mouse model of cigarette smoke extract-induced lung inflammation Source: Annual Congress 2007 - The best of airway epithelial cells Year: 2007 Exhaled hydrogen peroxide in patients with stable chronic obstructive pulmonary disease: effect of cigarette smoking Source: Eur Respir J 2006; 28: Suppl. 50, 626s Year: 2006 Effects of smoking cessation in COPD Source: Annual Congress 2006 - Smoking and COPD: will it ever vanish into smoke? Year: 2006